Antaros Medical

Antaros Medical specializes in providing innovative medical imaging solutions—primarily advanced MRI and PET techniques—to support evidence-based decision-making in pharmaceutical clinical drug development. The company partners with both large pharma and biotech firms to design and deliver mechanistic studies as well as global multi-center imaging trials. Their expertise spans cardiometabolic, renal, hepatic, fibrotic, neurological, musculoskeletal disorders, obesity/diabetes/metabolic syndrome, and oncology. They are recognized for pioneering new biomarkers such as novel PET tracers targeting PDGFRβ for fibrotic disease research. Antaros does not develop its own therapeutics but enables more effective drug R&D through its technology platforms.